Facilitated By

San Antonio Medical Foundation

A Collaboration of the San Antonio Bioscience and Medical Research Community

A first-of-its-kind initiative between public and private sector to catalog and highlight Bioscience research in the city of San Antonio and the surrounding areas.

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations

A Master Protocol Of Phase 1/2 Studies Of Nivolumab In Advanced Nsclc Using Nivolumab As Maintenance After Induction Chemotherapy Or As First-Line Treatment Alone Or In Combination With Standard Of Care Therapies

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide, accounting for approximately 18% of all cancer deaths.1 Despite treatment with platinum-based chemotherapy, the standard of care for first-line therapy, patients with metastatic NSCLC have a median survival of approximately 10 months, and a 5-year survival rate of less than 5%. Immunotherapeutic approaches have demonstrated clinical efficacy in several cancer types, including melanoma, hormone-refractory prostate cancer, and lung cancer.3,4.

Brooke Army Medical Center
Email for information
More Info
PROJECTION SPECIFIC DOPAMINERGIC NEURON PLASTICITY IN THE MIDBRAIN AND THE EFFECTS OF COCAINE

Cocaine use disorder is a chronic disease that takes a huge toll on society, and there is currently a lackof understanding of the cellular and circuit adaptations that take place in response to contingent drug use.While studies have examined excitatory signaling, there has been less focus on inhibitoryneurotransmission in brain regions that play a central role in addictive behaviors.

UT Health San Antonio
Hager, Audrey
More Info